A Program at Risk
The 340B program was created to help hospitals, clinics, and care centers provide care for vulnerable populations and underserved communities. Drug companies provide steep discounts on prescription medication, and in return, 340B health care centers called covered entities reinvest savings into affordable medicines and patient services. But evidence suggests covered entities often fail to live up to that promise. 340B is off track, and it’s at risk.
The initiative serves as a platform for stakeholders to:
-
Engage in policy discussions about the drug discount program.
-
Raise awareness about the negative impacts of expanding the broken system.
-
Encourage policymakers to take a balanced patient-centered approach to 340B policy.
Recent resources
How 340B Incentivizes Health Care Consolidation
September 21, 2026
A patient walks into their oncologist's office for a routine follow-up: same doctor, same waiting room, same blood draw she's had for years. Then the bill arrives: four times what she paid last time for the same visit. One reason for the increase in hospital acquisition of independent practices is the federal 340B drug discount program available to qualifying hospitals.
